Figure 4.

A probabilistic scatter plot of the incremental cost-effectiveness ratio (ICER) between the Control and Gefitinib strategies for a cohort of 1,000 patients. Each dot represents the ICER for 1 simulation. An ellipse surrounds 95% of the estimates. Dots that are located below the ICER threshold represent cost-effective simulations for the active strategy compared with the Control strategy.

Zhu et al. BMC Cancer 2013 13:39   doi:10.1186/1471-2407-13-39
Download authors' original image